← All stocks

CURIS INC

CRIS Net selling
CIK 0001108205 #5492 in the set updated 21 Sep 2026
Bought (120 mo)
$82.99K
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$1.27M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.27M
26 of 26 sales
Net
−$1.19M
−$1.19M against sales at will

By person

12 insiders · 33 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
MCNAB JAMES R
Director
$1.10M (13)
−$1.10M
929,688
$510.12K
−32.6%
Dentzer James E
President & CEO
$92.38K (8)
−$92.38K
148,730
$81.61K
Fattaey Ali Ph.D.
President & CEO
$53.00K (1)
+$53.00K
322,140
$176.76K
+388.9%
GREENACRE MARTYN D
Director
$19.47K (1)
−$19.47K
26,089
$14.32K
Kunkel Lori Anne
Director
$15.58K (1)
−$15.58K
22,200
$12.18K
KAITIN KENNETH I
Director
$5.49K (1)
$15.59K (1)
−$10.10K
11,407
$6.26K
Martell Robert
Head of Research & Development
$5.90K (1)
−$5.90K
23,027
$12.63K
Rubin Marc
Director
$24.50K (1)
$19.48K (1)
+$5.02K
28,108
$15.42K
Tuck David
Chief Medical Officer
169,424
$92.96K
+374.9%
Duvall Diantha
CFO
77,707
$42.64K
+603.8%
Zung Jonathan B.
CDO
66,667
$36.58K
Hamdy Ahmed MD
CMO
66,667
$36.58K

No percentages here. This company's share count has moved by a factor of 19.1 over the window, from 2,090,077 to 39,978,693 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
KAITIN KENNETH I
31 Mar 2026
Director
Buy
10,000
$0.55
$5.49K
Dentzer James E
31 Jan 2022
President & CEO
Sell
3,094
$3.07
$9.50K
Dentzer James E
27 Jan 2022
President & CEO
Sell
2,406
$3.18
$7.65K
Dentzer James E
26 Jan 2021
President & CEO
Sell
3,094
$10.59
$32.76K
Dentzer James E
25 Jan 2021
President & CEO
Sell
2,283
$10.96
$25.02K
Dentzer James E
24 Jan 2020
President & CEO
Sell
3,094
$1.64
$5.08K
Dentzer James E
23 Jan 2020
President & CEO
Sell
3,658
$1.69
$6.18K
Dentzer James E
24 Jan 2019
President & CEO
Sell
3,094
$1.16
$3.58K
KAITIN KENNETH I
23 Jan 2019
Director
Sell
14,800
$1.05
$15.59K
Kunkel Lori Anne
23 Jan 2019
Director
Sell
14,800
$1.05
$15.58K
Rubin Marc
23 Jan 2019
Director
Sell
18,500
$1.05
$19.48K
GREENACRE MARTYN D
23 Jan 2019
Director
Sell
18,500
$1.05
$19.47K
Martell Robert
23 Jan 2019
Head of Research & Development
Sell
5,500
$1.07
$5.90K
Dentzer James E
23 Jan 2019
President & CEO
Sell
2,397
$1.09
$2.61K
Rubin Marc
16 Nov 2017
Director
Buy
25,000
$0.98
$24.50K
Fattaey Ali Ph.D.
15 Nov 2017
President & CEO
Buy
50,000
$1.06
$53.00K
KAITIN KENNETH I
31 May 2017
Director
Exercised, kept
5,000
$1.39
$6.95K
KAITIN KENNETH I
31 May 2017
Director
Exercised, kept
10,000
$1.39
$13.90K
GREENACRE MARTYN D
31 May 2017
Director
Exercised, kept
5,000
$1.39
$6.95K
GREENACRE MARTYN D
31 May 2017
Director
Exercised, kept
10,000
$1.39
$13.90K
MCNAB JAMES R
5 May 2017
Director
Sell indirect
16,176
$1.90
$30.72K
MCNAB JAMES R
4 May 2017
Director
Sell indirect
30,100
$1.97
$59.16K
MCNAB JAMES R
3 May 2017
Director
Sell indirect
30,000
$2.18
$65.54K
MCNAB JAMES R
2 May 2017
Director
Sell indirect
35,646
$2.31
$82.31K
MCNAB JAMES R
1 May 2017
Director
Sell indirect
38,113
$2.38
$90.71K
MCNAB JAMES R
28 Apr 2017
Director
Sell indirect
42,949
$2.45
$105.01K
MCNAB JAMES R
27 Apr 2017
Director
Sell indirect
37,202
$2.57
$95.62K
MCNAB JAMES R
26 Apr 2017
Director
Sell indirect
19,814
$2.65
$52.44K
MCNAB JAMES R
26 Apr 2017
Director
Sell
32,738
$2.65
$86.65K
MCNAB JAMES R
25 Apr 2017
Director
Sell
56,940
$2.60
$148.31K
MCNAB JAMES R
24 Apr 2017
Director
Sell
42,076
$2.56
$107.86K
MCNAB JAMES R
21 Apr 2017
Director
Sell
45,705
$2.58
$117.84K
MCNAB JAMES R
20 Apr 2017
Director
Sell
22,541
$2.66
$59.98K

What was left out

Form 4 filings counted 125
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 26
Transactions with no price 0
Shares from compensation/vesting 1,894,109
Sales filed before the plan box existed 26
History held since 9 Sep 2016